EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The place of adamantane derivatives in modern neuropsychopharmacological practice

Valentin E. Marievskiy, Yuliya S. Belikova, Nikolay L. Shimanovskiy

Psychopharmacology and Addiction Biology · 17.05.2026 · 17 (2) · 57-69

DOI: 10.17816/phbn703741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychopharmacology and Addiction Biology, online erschienen am 17.05.2026. Verfasst von Valentin E. Marievskiy und 2 weiteren Autor:innen. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This narrative review examines the current status of adamantane derivatives in neuropsychopharmacological practice. It describes in detail the mechanisms of action of the compounds in this group—amantadine and memantine—as well as their clinical use. The search for publications was performed using the PubMed, Scopus, and Web of Science databases; the review included works published up to and including January 2026. Adamantane derivatives remain relevant drugs in the pharmacotherapy of neurodegenerative diseases. Thus, amantadine is used to treat Parkinson disease and other forms of parkinsonism (both as monotherapy and as part of combination therapy for the correction of levodopa-induced dyskinesias), and memantine is used to treat Alzheimer disease (both as monotherapy and as part of combination therapy with anticholinesterase agents). However, these drugs are also used for off-label indications: amantadine for vigilance disorders, neuropathic pain, and Huntington disease; memantine for other tauopathies, dementia with Lewy bodies, frontotemporal and vascular dementia, as well as dementia associated with Parkinson disease. The mechanism of action of adamantane derivatives is based on the blockade of NMDA receptors, leading to a decrease in glutamatergic excitotoxicity, as well as agonism toward sigma-1 receptors and suppression of microglial pro-inflammatory factor production, which collectively has a neuroprotective effect. It is worth noting that in the spectrum of action of adamantane derivatives, dopamine-positive and anticholinergic (amantadine), as well as serotonin-positive and N-cholinolytic (memantine) effects can be distinguished, which explains such diverse use of these drugs. Adamantane derivatives have a favorable safety profile; however, headaches, confusion, constipation, and peripheral edema are rarely observed with their use. In general, adamantane derivatives can be described as effective and well-tolerated medications that remain relevant tools in neurological practice.

Zitieren

APA

Marievskiy, V. E., Belikova, Y. S., & Shimanovskiy, N. L. (2026). The place of adamantane derivatives in modern neuropsychopharmacological practice. Psychopharmacology and Addiction Biology, 17(2), 57-69. https://doi.org/10.17816/phbn703741

Vancouver

Marievskiy VE, Belikova YS, Shimanovskiy NL. The place of adamantane derivatives in modern neuropsychopharmacological practice. Psychopharmacology and Addiction Biology. 2026;17(2):57-69. doi:10.17816/phbn703741

BibTeX
@article{Marievskiy2026,
  author = {Marievskiy, Valentin E. and Belikova, Yuliya S. and Shimanovskiy, Nikolay L.},
  title = {The place of adamantane derivatives in modern neuropsychopharmacological practice},
  journal = {Psychopharmacology and Addiction Biology},
  year = {2026},
  volume = {17},
  number = {2},
  pages = {57--69},
  doi = {10.17816/phbn703741}
}
Kostenlos starten →